nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefuroxime—Vaginal discharge—Methotrexate—ankylosing spondylitis	0.0134	0.0134	CcSEcCtD
Cefuroxime—Liver disorder—Methotrexate—ankylosing spondylitis	0.0119	0.0119	CcSEcCtD
Cefuroxime—Candida infection—Triamcinolone—ankylosing spondylitis	0.0117	0.0117	CcSEcCtD
Cefuroxime—Thrombophlebitis—Prednisolone—ankylosing spondylitis	0.0112	0.0112	CcSEcCtD
Cefuroxime—Thrombophlebitis—Triamcinolone—ankylosing spondylitis	0.0103	0.0103	CcSEcCtD
Cefuroxime—Thrombophlebitis—Methylprednisolone—ankylosing spondylitis	0.0103	0.0103	CcSEcCtD
Cefuroxime—Blood alkaline phosphatase increased—Methylprednisolone—ankylosing spondylitis	0.0102	0.0102	CcSEcCtD
Cefuroxime—Thrombophlebitis—Betamethasone—ankylosing spondylitis	0.00936	0.00936	CcSEcCtD
Cefuroxime—Thrombophlebitis—Dexamethasone—ankylosing spondylitis	0.00936	0.00936	CcSEcCtD
Cefuroxime—Musculoskeletal stiffness—Methotrexate—ankylosing spondylitis	0.00905	0.00905	CcSEcCtD
Cefuroxime—Hepatic enzyme increased—Methotrexate—ankylosing spondylitis	0.00859	0.00859	CcSEcCtD
Cefuroxime—Irritability—Methylprednisolone—ankylosing spondylitis	0.0085	0.0085	CcSEcCtD
Cefuroxime—Hyperkinesia—Prednisone—ankylosing spondylitis	0.00848	0.00848	CcSEcCtD
Cefuroxime—Thrombophlebitis—Prednisone—ankylosing spondylitis	0.00815	0.00815	CcSEcCtD
Cefuroxime—Vaginal inflammation—Methotrexate—ankylosing spondylitis	0.00812	0.00812	CcSEcCtD
Cefuroxime—Irritability—Betamethasone—ankylosing spondylitis	0.00773	0.00773	CcSEcCtD
Cefuroxime—Irritability—Dexamethasone—ankylosing spondylitis	0.00773	0.00773	CcSEcCtD
Cefuroxime—Vaginal infection—Methotrexate—ankylosing spondylitis	0.00767	0.00767	CcSEcCtD
Cefuroxime—Aplastic anaemia—Methotrexate—ankylosing spondylitis	0.00763	0.00763	CcSEcCtD
Cefuroxime—Bronchitis—Triamcinolone—ankylosing spondylitis	0.00742	0.00742	CcSEcCtD
Cefuroxime—Mouth ulceration—Methotrexate—ankylosing spondylitis	0.00734	0.00734	CcSEcCtD
Cefuroxime—Upper respiratory tract infection—Triamcinolone—ankylosing spondylitis	0.00717	0.00717	CcSEcCtD
Cefuroxime—Infestation NOS—Methylprednisolone—ankylosing spondylitis	0.00687	0.00687	CcSEcCtD
Cefuroxime—Infestation—Methylprednisolone—ankylosing spondylitis	0.00687	0.00687	CcSEcCtD
Cefuroxime—Thrombophlebitis—Methotrexate—ankylosing spondylitis	0.00681	0.00681	CcSEcCtD
Cefuroxime—Haemoglobin—Prednisolone—ankylosing spondylitis	0.00675	0.00675	CcSEcCtD
Cefuroxime—Irritability—Prednisone—ankylosing spondylitis	0.00673	0.00673	CcSEcCtD
Cefuroxime—Haemorrhage—Prednisolone—ankylosing spondylitis	0.00672	0.00672	CcSEcCtD
Cefuroxime—Sweating—Methylprednisolone—ankylosing spondylitis	0.00658	0.00658	CcSEcCtD
Cefuroxime—Haemoglobin—Triamcinolone—ankylosing spondylitis	0.00621	0.00621	CcSEcCtD
Cefuroxime—Haemoglobin—Methylprednisolone—ankylosing spondylitis	0.00619	0.00619	CcSEcCtD
Cefuroxime—Haemorrhage—Triamcinolone—ankylosing spondylitis	0.00618	0.00618	CcSEcCtD
Cefuroxime—Haemorrhage—Methylprednisolone—ankylosing spondylitis	0.00616	0.00616	CcSEcCtD
Cefuroxime—Erythema—Prednisolone—ankylosing spondylitis	0.00585	0.00585	CcSEcCtD
Cefuroxime—Neutropenia—Prednisone—ankylosing spondylitis	0.0057	0.0057	CcSEcCtD
Cefuroxime—Haemoglobin—Betamethasone—ankylosing spondylitis	0.00563	0.00563	CcSEcCtD
Cefuroxime—Haemoglobin—Dexamethasone—ankylosing spondylitis	0.00563	0.00563	CcSEcCtD
Cefuroxime—Irritability—Methotrexate—ankylosing spondylitis	0.00563	0.00563	CcSEcCtD
Cefuroxime—Haemorrhage—Dexamethasone—ankylosing spondylitis	0.0056	0.0056	CcSEcCtD
Cefuroxime—Haemorrhage—Betamethasone—ankylosing spondylitis	0.0056	0.0056	CcSEcCtD
Cefuroxime—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.00559	0.00559	CcSEcCtD
Cefuroxime—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.00557	0.00557	CcSEcCtD
Cefuroxime—Erythema—Triamcinolone—ankylosing spondylitis	0.00538	0.00538	CcSEcCtD
Cefuroxime—Erythema—Methylprednisolone—ankylosing spondylitis	0.00536	0.00536	CcSEcCtD
Cefuroxime—Angioedema—Prednisolone—ankylosing spondylitis	0.00534	0.00534	CcSEcCtD
Cefuroxime—Toxic epidermal necrolysis—Methotrexate—ankylosing spondylitis	0.00531	0.00531	CcSEcCtD
Cefuroxime—Angiopathy—Dexamethasone—ankylosing spondylitis	0.00508	0.00508	CcSEcCtD
Cefuroxime—Angiopathy—Betamethasone—ankylosing spondylitis	0.00508	0.00508	CcSEcCtD
Cefuroxime—Convulsion—Prednisolone—ankylosing spondylitis	0.00507	0.00507	CcSEcCtD
Cefuroxime—Eosinophilia—Methotrexate—ankylosing spondylitis	0.00505	0.00505	CcSEcCtD
Cefuroxime—Angioedema—Triamcinolone—ankylosing spondylitis	0.00491	0.00491	CcSEcCtD
Cefuroxime—Haemoglobin—Prednisone—ankylosing spondylitis	0.00491	0.00491	CcSEcCtD
Cefuroxime—Angioedema—Methylprednisolone—ankylosing spondylitis	0.0049	0.0049	CcSEcCtD
Cefuroxime—Haemorrhage—Prednisone—ankylosing spondylitis	0.00488	0.00488	CcSEcCtD
Cefuroxime—Erythema—Dexamethasone—ankylosing spondylitis	0.00488	0.00488	CcSEcCtD
Cefuroxime—Erythema—Betamethasone—ankylosing spondylitis	0.00488	0.00488	CcSEcCtD
Cefuroxime—Pancytopenia—Methotrexate—ankylosing spondylitis	0.00484	0.00484	CcSEcCtD
Cefuroxime—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00477	0.00477	CcSEcCtD
Cefuroxime—Neutropenia—Methotrexate—ankylosing spondylitis	0.00477	0.00477	CcSEcCtD
Cefuroxime—Dysuria—Methotrexate—ankylosing spondylitis	0.00477	0.00477	CcSEcCtD
Cefuroxime—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.00474	0.00474	CcSEcCtD
Cefuroxime—Cough—Triamcinolone—ankylosing spondylitis	0.00469	0.00469	CcSEcCtD
Cefuroxime—Convulsion—Triamcinolone—ankylosing spondylitis	0.00466	0.00466	CcSEcCtD
Cefuroxime—Tachycardia—Prednisolone—ankylosing spondylitis	0.00466	0.00466	CcSEcCtD
Cefuroxime—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00465	0.00465	CcSEcCtD
Cefuroxime—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00461	0.00461	CcSEcCtD
Cefuroxime—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.00457	0.00457	CcSEcCtD
Cefuroxime—Infestation NOS—Methotrexate—ankylosing spondylitis	0.00454	0.00454	CcSEcCtD
Cefuroxime—Infestation—Methotrexate—ankylosing spondylitis	0.00454	0.00454	CcSEcCtD
Cefuroxime—Drowsiness—Methotrexate—ankylosing spondylitis	0.00454	0.00454	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00454	0.00454	CcSEcCtD
Cefuroxime—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.0045	0.0045	CcSEcCtD
Cefuroxime—Renal failure—Methotrexate—ankylosing spondylitis	0.00447	0.00447	CcSEcCtD
Cefuroxime—Angioedema—Betamethasone—ankylosing spondylitis	0.00446	0.00446	CcSEcCtD
Cefuroxime—Angioedema—Dexamethasone—ankylosing spondylitis	0.00446	0.00446	CcSEcCtD
Cefuroxime—Stomatitis—Methotrexate—ankylosing spondylitis	0.00443	0.00443	CcSEcCtD
Cefuroxime—Angiopathy—Prednisone—ankylosing spondylitis	0.00443	0.00443	CcSEcCtD
Cefuroxime—Immune system disorder—Prednisone—ankylosing spondylitis	0.00441	0.00441	CcSEcCtD
Cefuroxime—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00439	0.00439	CcSEcCtD
Cefuroxime—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00438	0.00438	CcSEcCtD
Cefuroxime—Sweating—Methotrexate—ankylosing spondylitis	0.00436	0.00436	CcSEcCtD
Cefuroxime—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.0043	0.0043	CcSEcCtD
Cefuroxime—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00428	0.00428	CcSEcCtD
Cefuroxime—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00427	0.00427	CcSEcCtD
Cefuroxime—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00425	0.00425	CcSEcCtD
Cefuroxime—Erythema—Prednisone—ankylosing spondylitis	0.00425	0.00425	CcSEcCtD
Cefuroxime—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00424	0.00424	CcSEcCtD
Cefuroxime—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.00424	0.00424	CcSEcCtD
Cefuroxime—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00423	0.00423	CcSEcCtD
Cefuroxime—Convulsion—Dexamethasone—ankylosing spondylitis	0.00423	0.00423	CcSEcCtD
Cefuroxime—Convulsion—Betamethasone—ankylosing spondylitis	0.00423	0.00423	CcSEcCtD
Cefuroxime—Haemoglobin—Methotrexate—ankylosing spondylitis	0.0041	0.0041	CcSEcCtD
Cefuroxime—Pain—Prednisolone—ankylosing spondylitis	0.00408	0.00408	CcSEcCtD
Cefuroxime—Haemorrhage—Methotrexate—ankylosing spondylitis	0.00408	0.00408	CcSEcCtD
Cefuroxime—Hepatitis—Methotrexate—ankylosing spondylitis	0.00408	0.00408	CcSEcCtD
Cefuroxime—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00403	0.00403	CcSEcCtD
Cefuroxime—Urethral disorder—Methotrexate—ankylosing spondylitis	0.004	0.004	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.004	0.004	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00399	0.00399	CcSEcCtD
Cefuroxime—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00398	0.00398	CcSEcCtD
Cefuroxime—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00398	0.00398	CcSEcCtD
Cefuroxime—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00391	0.00391	CcSEcCtD
Cefuroxime—Agitation—Prednisone—ankylosing spondylitis	0.0039	0.0039	CcSEcCtD
Cefuroxime—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.0039	0.0039	CcSEcCtD
Cefuroxime—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.0039	0.0039	CcSEcCtD
Cefuroxime—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00389	0.00389	CcSEcCtD
Cefuroxime—Tachycardia—Betamethasone—ankylosing spondylitis	0.00389	0.00389	CcSEcCtD
Cefuroxime—Angioedema—Prednisone—ankylosing spondylitis	0.00388	0.00388	CcSEcCtD
Cefuroxime—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00386	0.00386	CcSEcCtD
Cefuroxime—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.00386	0.00386	CcSEcCtD
Cefuroxime—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00385	0.00385	CcSEcCtD
Cefuroxime—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00385	0.00385	CcSEcCtD
Cefuroxime—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00385	0.00385	CcSEcCtD
Cefuroxime—Anorexia—Dexamethasone—ankylosing spondylitis	0.0038	0.0038	CcSEcCtD
Cefuroxime—Anorexia—Betamethasone—ankylosing spondylitis	0.0038	0.0038	CcSEcCtD
Cefuroxime—Urticaria—Prednisolone—ankylosing spondylitis	0.00379	0.00379	CcSEcCtD
Cefuroxime—Pain—Triamcinolone—ankylosing spondylitis	0.00375	0.00375	CcSEcCtD
Cefuroxime—Angiopathy—Methotrexate—ankylosing spondylitis	0.0037	0.0037	CcSEcCtD
Cefuroxime—Immune system disorder—Methotrexate—ankylosing spondylitis	0.00368	0.00368	CcSEcCtD
Cefuroxime—Convulsion—Prednisone—ankylosing spondylitis	0.00368	0.00368	CcSEcCtD
Cefuroxime—Chills—Methotrexate—ankylosing spondylitis	0.00366	0.00366	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00363	0.00363	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00363	0.00363	CcSEcCtD
Cefuroxime—Arthralgia—Prednisone—ankylosing spondylitis	0.00362	0.00362	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00359	0.00359	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00358	0.00358	CcSEcCtD
Cefuroxime—Erythema—Methotrexate—ankylosing spondylitis	0.00355	0.00355	CcSEcCtD
Cefuroxime—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00352	0.00352	CcSEcCtD
Cefuroxime—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.0035	0.0035	CcSEcCtD
Cefuroxime—Dyspepsia—Betamethasone—ankylosing spondylitis	0.0035	0.0035	CcSEcCtD
Cefuroxime—Urticaria—Triamcinolone—ankylosing spondylitis	0.00349	0.00349	CcSEcCtD
Cefuroxime—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00348	0.00348	CcSEcCtD
Cefuroxime—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00347	0.00347	CcSEcCtD
Cefuroxime—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.00347	0.00347	CcSEcCtD
Cefuroxime—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00346	0.00346	CcSEcCtD
Cefuroxime—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00346	0.00346	CcSEcCtD
Cefuroxime—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00346	0.00346	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00344	0.00344	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00344	0.00344	CcSEcCtD
Cefuroxime—Pain—Dexamethasone—ankylosing spondylitis	0.0034	0.0034	CcSEcCtD
Cefuroxime—Pain—Betamethasone—ankylosing spondylitis	0.0034	0.0034	CcSEcCtD
Cefuroxime—Tachycardia—Prednisone—ankylosing spondylitis	0.00338	0.00338	CcSEcCtD
Cefuroxime—Skin disorder—Prednisone—ankylosing spondylitis	0.00337	0.00337	CcSEcCtD
Cefuroxime—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00335	0.00335	CcSEcCtD
Cefuroxime—Anorexia—Prednisone—ankylosing spondylitis	0.00331	0.00331	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00326	0.00326	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00326	0.00326	CcSEcCtD
Cefuroxime—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00323	0.00323	CcSEcCtD
Cefuroxime—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00323	0.00323	CcSEcCtD
Cefuroxime—Leukopenia—Methotrexate—ankylosing spondylitis	0.00318	0.00318	CcSEcCtD
Cefuroxime—Urticaria—Betamethasone—ankylosing spondylitis	0.00316	0.00316	CcSEcCtD
Cefuroxime—Urticaria—Dexamethasone—ankylosing spondylitis	0.00316	0.00316	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00316	0.00316	CcSEcCtD
Cefuroxime—Dizziness—Prednisolone—ankylosing spondylitis	0.00316	0.00316	CcSEcCtD
Cefuroxime—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00315	0.00315	CcSEcCtD
Cefuroxime—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00315	0.00315	CcSEcCtD
Cefuroxime—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00315	0.00315	CcSEcCtD
Cefuroxime—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00315	0.00315	CcSEcCtD
Cefuroxime—Pruritus—Triamcinolone—ankylosing spondylitis	0.0031	0.0031	CcSEcCtD
Cefuroxime—Cough—Methotrexate—ankylosing spondylitis	0.0031	0.0031	CcSEcCtD
Cefuroxime—Pruritus—Methylprednisolone—ankylosing spondylitis	0.0031	0.0031	CcSEcCtD
Cefuroxime—Convulsion—Methotrexate—ankylosing spondylitis	0.00308	0.00308	CcSEcCtD
Cefuroxime—Dyspepsia—Prednisone—ankylosing spondylitis	0.00305	0.00305	CcSEcCtD
Cefuroxime—Arthralgia—Methotrexate—ankylosing spondylitis	0.00302	0.00302	CcSEcCtD
Cefuroxime—Chest pain—Methotrexate—ankylosing spondylitis	0.00302	0.00302	CcSEcCtD
Cefuroxime—Decreased appetite—Prednisone—ankylosing spondylitis	0.00301	0.00301	CcSEcCtD
Cefuroxime—Rash—Prednisolone—ankylosing spondylitis	0.00301	0.00301	CcSEcCtD
Cefuroxime—Dermatitis—Prednisolone—ankylosing spondylitis	0.00301	0.00301	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.003	0.003	CcSEcCtD
Cefuroxime—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.003	0.003	CcSEcCtD
Cefuroxime—Headache—Prednisolone—ankylosing spondylitis	0.00299	0.00299	CcSEcCtD
Cefuroxime—Dizziness—Triamcinolone—ankylosing spondylitis	0.0029	0.0029	CcSEcCtD
Cefuroxime—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.0029	0.0029	CcSEcCtD
Cefuroxime—Dizziness—Methylprednisolone—ankylosing spondylitis	0.0029	0.0029	CcSEcCtD
Cefuroxime—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.00284	0.00284	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00284	0.00284	CcSEcCtD
Cefuroxime—Nausea—Prednisolone—ankylosing spondylitis	0.00283	0.00283	CcSEcCtD
Cefuroxime—Pruritus—Betamethasone—ankylosing spondylitis	0.00282	0.00282	CcSEcCtD
Cefuroxime—Pruritus—Dexamethasone—ankylosing spondylitis	0.00282	0.00282	CcSEcCtD
Cefuroxime—Skin disorder—Methotrexate—ankylosing spondylitis	0.00281	0.00281	CcSEcCtD
Cefuroxime—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.0028	0.0028	CcSEcCtD
Cefuroxime—Vomiting—Triamcinolone—ankylosing spondylitis	0.00279	0.00279	CcSEcCtD
Cefuroxime—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00278	0.00278	CcSEcCtD
Cefuroxime—Rash—Triamcinolone—ankylosing spondylitis	0.00277	0.00277	CcSEcCtD
Cefuroxime—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00276	0.00276	CcSEcCtD
Cefuroxime—Anorexia—Methotrexate—ankylosing spondylitis	0.00276	0.00276	CcSEcCtD
Cefuroxime—Rash—Methylprednisolone—ankylosing spondylitis	0.00276	0.00276	CcSEcCtD
Cefuroxime—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00276	0.00276	CcSEcCtD
Cefuroxime—Urticaria—Prednisone—ankylosing spondylitis	0.00275	0.00275	CcSEcCtD
Cefuroxime—Headache—Triamcinolone—ankylosing spondylitis	0.00275	0.00275	CcSEcCtD
Cefuroxime—Headache—Methylprednisolone—ankylosing spondylitis	0.00274	0.00274	CcSEcCtD
Cefuroxime—Abdominal pain—Prednisone—ankylosing spondylitis	0.00274	0.00274	CcSEcCtD
Cefuroxime—Body temperature increased—Prednisone—ankylosing spondylitis	0.00274	0.00274	CcSEcCtD
Cefuroxime—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00272	0.00272	CcSEcCtD
Cefuroxime—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00272	0.00272	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00264	0.00264	CcSEcCtD
Cefuroxime—Dizziness—Betamethasone—ankylosing spondylitis	0.00263	0.00263	CcSEcCtD
Cefuroxime—Dizziness—Dexamethasone—ankylosing spondylitis	0.00263	0.00263	CcSEcCtD
Cefuroxime—Nausea—Triamcinolone—ankylosing spondylitis	0.00261	0.00261	CcSEcCtD
Cefuroxime—Nausea—Methylprednisolone—ankylosing spondylitis	0.0026	0.0026	CcSEcCtD
Cefuroxime—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00258	0.00258	CcSEcCtD
Cefuroxime—Somnolence—Methotrexate—ankylosing spondylitis	0.00258	0.00258	CcSEcCtD
Cefuroxime—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00255	0.00255	CcSEcCtD
Cefuroxime—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00255	0.00255	CcSEcCtD
Cefuroxime—Vomiting—Dexamethasone—ankylosing spondylitis	0.00253	0.00253	CcSEcCtD
Cefuroxime—Vomiting—Betamethasone—ankylosing spondylitis	0.00253	0.00253	CcSEcCtD
Cefuroxime—Decreased appetite—Methotrexate—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Cefuroxime—Rash—Dexamethasone—ankylosing spondylitis	0.00251	0.00251	CcSEcCtD
Cefuroxime—Rash—Betamethasone—ankylosing spondylitis	0.00251	0.00251	CcSEcCtD
Cefuroxime—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00251	0.00251	CcSEcCtD
Cefuroxime—Dermatitis—Betamethasone—ankylosing spondylitis	0.00251	0.00251	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.0025	0.0025	CcSEcCtD
Cefuroxime—Headache—Betamethasone—ankylosing spondylitis	0.00249	0.00249	CcSEcCtD
Cefuroxime—Headache—Dexamethasone—ankylosing spondylitis	0.00249	0.00249	CcSEcCtD
Cefuroxime—Pain—Methotrexate—ankylosing spondylitis	0.00248	0.00248	CcSEcCtD
Cefuroxime—Pruritus—Prednisone—ankylosing spondylitis	0.00245	0.00245	CcSEcCtD
Cefuroxime—Diarrhoea—Prednisone—ankylosing spondylitis	0.00237	0.00237	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00237	0.00237	CcSEcCtD
Cefuroxime—Nausea—Betamethasone—ankylosing spondylitis	0.00237	0.00237	CcSEcCtD
Cefuroxime—Nausea—Dexamethasone—ankylosing spondylitis	0.00237	0.00237	CcSEcCtD
Cefuroxime—Urticaria—Methotrexate—ankylosing spondylitis	0.0023	0.0023	CcSEcCtD
Cefuroxime—Dizziness—Prednisone—ankylosing spondylitis	0.00229	0.00229	CcSEcCtD
Cefuroxime—Body temperature increased—Methotrexate—ankylosing spondylitis	0.00229	0.00229	CcSEcCtD
Cefuroxime—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00229	0.00229	CcSEcCtD
Cefuroxime—Vomiting—Prednisone—ankylosing spondylitis	0.0022	0.0022	CcSEcCtD
Cefuroxime—Rash—Prednisone—ankylosing spondylitis	0.00219	0.00219	CcSEcCtD
Cefuroxime—Dermatitis—Prednisone—ankylosing spondylitis	0.00218	0.00218	CcSEcCtD
Cefuroxime—Headache—Prednisone—ankylosing spondylitis	0.00217	0.00217	CcSEcCtD
Cefuroxime—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00214	0.00214	CcSEcCtD
Cefuroxime—Nausea—Prednisone—ankylosing spondylitis	0.00206	0.00206	CcSEcCtD
Cefuroxime—Pruritus—Methotrexate—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Cefuroxime—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00198	0.00198	CcSEcCtD
Cefuroxime—Dizziness—Methotrexate—ankylosing spondylitis	0.00192	0.00192	CcSEcCtD
Cefuroxime—Vomiting—Methotrexate—ankylosing spondylitis	0.00184	0.00184	CcSEcCtD
Cefuroxime—Rash—Methotrexate—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Cefuroxime—Dermatitis—Methotrexate—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Cefuroxime—Headache—Methotrexate—ankylosing spondylitis	0.00182	0.00182	CcSEcCtD
Cefuroxime—Nausea—Methotrexate—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
